REGENERX BIOPHARMACEUTICALS INC Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Regenerx Biopharmaceuticals Inc quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2018 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending March 31, 2023 was $9.45K, a 1281% increase year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $9.45K +$8.76K +1281% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $13K +$11.1K +588% Dec 31, 2022 10-K 2023-04-11
Q3 2022 $16.6K +$13K +357% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $70.00 -$5.86K -98.8% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $684 -$8.04K -92.2% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.89K -$10.1K -84.3% Dec 31, 2021 10-K 2022-03-30
Q3 2021 $3.64K -$12.1K -76.8% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $5.93K -$14K -70.2% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $8.73K +$8.06K +1206% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $12K +$10.2K +554% Dec 31, 2020 10-K 2021-03-02
Q3 2020 $15.7K +$12.2K +345% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $19.9K +$14.2K +247% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $668 -$7.74K -92.1% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $1.84K -$75.2K -97.6% Dec 31, 2019 10-K 2020-03-20
Q3 2019 $3.53K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $5.73K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $8.41K Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $77K Dec 31, 2018 10-K 2019-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.